Holding company for drug discovery subsidiaries, developing anti-cancer compounds in clinical stage, and addiction vaccines. Includes candidates for therapeutic focus, investor details, with contacts in Slough and Cambridge, England. (Nasdaq: XNVA)
Xenova Group plc